☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Factor VIII Inhibitors
Roche's Hemlibra Receives EU's Approval for Severe Haemophilia A without Factor VIII Inhibitors
March 14, 2019
Roche's Hemlibra Receives the US FDA Approval for Haemophilia A Without Factor VIII Inhibitors
October 5, 2018
Roche's Hemlibra Receives FDA's Breakthrough Therapy Designation for Hemophilia A without Factor VIII Inhibitors
April 17, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.